Prado HEN, Ferrufino MBR, Ferrufino MMA, Vázquez NJR, Vargas DCI

Language: Spanish
References: 13
Page: 28-37
PDF size: 340.26 Kb.

ABSTRACT

Introduction: One of the greatest challenges in oncological surgery is to individualize the management of each patient. Remembering that each patient will have individual characteristics, pathologies and unique history, which makes the therapeutic approach more complex.
Case presentation: This is a 49-year-old female patient with 3-month onset of symptoms, with increased volume in the right periorbital region, intense headache in the occipital and frontal regions, loss of visual acuity in the right eye. Imaging studies are performed, finding an occupying lesion in the ethmoid cells, frontal and sphenoid sinuses, so a biopsy of the lesion is performed with a pathology report of squamous cell carcinoma of basaloid cells, and the decision is made to perform a combined surgical treatment, performing a frontal approach and endoscopic transnasal approach.
Conclusions: In the literature review, a small number of cases of patients with squamous cell carcinoma of basaloid cells in the nasal cavity with infiltration to the brain have been reported, so the treatment is not yet standardized, however multidisciplinary treatment is the basis for success and patient prognosis.

REFERENCES

1. Querleu D, Cibula D, Abu-Rustum NR. 2017 update onthe Querleu-Morrow classification of radical hysterectomy.Ann Surg Oncol. 2017;24(11):3406-3412. doi: 10.1245/s10434-017-6031-z.

2. Manickavasagar R, Thuraisingham R. Post renal-transplantmalignancy surveillance. Clin Med (Lond). 2020;20(2):142-5.

3. Park ST, Song MJ. Incidence and clinicopathologic behaviorof uterine cervical carcinoma in renal transplant recipients.World J Surg Oncol. 2011;9:72.

4. Sun J, Yue Y, Li R, Sun Q, Hu C, Ge X, Guan Q. Detectionof HPV E6/E7 mRNA in the diagnosis of cervical cancerand precancerous lesions after kidney transplantation. AmJ Transl Res. 2021;13(6):7312-7317. Disponible en: www.ajtr.org /ISSN:1943-8141/AJTR0132160.

5. Hsu DW, Chang CM, Hsu CS, Yin WY. Minimally invasivesurgery is feasible in patients with liver and kidney transplantation.Ann Transplant. 2020;25:e922602.

6. Matylevich OP, Shushkevich AB. Modified combined radiotherapyfor cervical cancer in kidney transplant recipient.Clin Case Rep. 2021;9:2088-2093.

7. Valdespino-Castillo VE, Maytorena-Córdova G. Resecciónganglionar retroperitoneal en el cáncer ginecológico: utilidadcomo biomarcador predictivo. Ginecol Obstet Mex.2018;86(7):464-477.

8. Reinholdt K, Thomsen LT, Dehlendorff C. Human papillomavirus-related anogenital premalignancies and cancer in renaltransplant recipients: A Danish nationwide, registry-basedcohort study. Int J Cancer. 2020;146(9):2413-2422.

9. Chin-Hong P. Human papillomavirus in kidney transplantrecipients. Semin Nephrol. 2016;36(5):397-404. doi:

10. 10.1016/j.semnephrol.2016.05.016.10. Chaung KV, Zheng Y, Martella AT, Stoecker JB. Riskfactors for abnormal cervical cytology in women undergoingkidney transplant evaluation. Exp Clin Transplant.2019;17(1):31-36.

11. Sugarbaker PH. Technical handbook for the integration of cytoreductivesurgery and perioperative intraperitoneal chemotherapyinto the surgical management of gastrointestinal andgynecologic malignancy. Cancer Res. 2016;50:5790-5794.

12. Wong G, Howard K, Webster A, Chapman JR. The healthand economic impact of cervical cancer screening and humanpapillomavirus vaccination in kidney transplant recipients.Transplantation. 2019;87(7):1020-1029.

13. Diaz de Vivar A, Roma AA, Park KJ. Invasive endocervicaladenocarcinoma: Proposal for a new pattern-based classificationsystem with significant clinical implications: A multi-institutionalstudy. Int J Gynecol Pathol. 2013;32(6):592-601.